An official website of the United States government
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

The most recent appropriations for the Department of War expired at 11:59 p.m. EST on September 30, 2025. Military personnel will continue in a normal duty status without pay until such time as a continuing resolution or appropriations are passed by Congress and signed into law. Civilian personnel not engaged in excepted activities will be placed in a non-work, non-pay status.
If you have a scheduled appointment or other business at the MTF, please verify with your provider or applicable office within the MTF to ensure there are no changes in schedule. To learn how the lapse in appropriations affects your TRICARE benefit, visit tricare.mil/shutdown.
News | Aug. 16, 2021

Monoclonal antibody treatment can help some COVID-positive patients

By Lori Newman

JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas  –   Brooke Army Medical Center doctors are working with the Southwest Texas Regional Advisory Council to help COVID patients receive the monoclonal antibody treatment and potentially lessen the severity of the illness.

Some early evidence suggests monoclonal antibody treatment can reduce the amount of the SARS-CoV-2 virus, the virus that causes COVID-19, in a person's system. This means the patient may have milder symptoms thereby decreasing the likelihood of being hospitalized.

“The goal of this treatment is to halt the progression of COVID, and to hopefully prevent inpatient admission,” said Air Force Maj. (Dr.) Joseph Yabes Jr., infectious disease physician. “Overall, people have had good responses to this therapy.”

Full Story
News | Aug. 16, 2021

Monoclonal antibody treatment can help some COVID-positive patients

By Lori Newman

JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas  –   Brooke Army Medical Center doctors are working with the Southwest Texas Regional Advisory Council to help COVID patients receive the monoclonal antibody treatment and potentially lessen the severity of the illness.

Some early evidence suggests monoclonal antibody treatment can reduce the amount of the SARS-CoV-2 virus, the virus that causes COVID-19, in a person's system. This means the patient may have milder symptoms thereby decreasing the likelihood of being hospitalized.

“The goal of this treatment is to halt the progression of COVID, and to hopefully prevent inpatient admission,” said Air Force Maj. (Dr.) Joseph Yabes Jr., infectious disease physician. “Overall, people have had good responses to this therapy.”

Full Story
Don’t forget to keep your family’s information up to date in DEERS!